Dexamethasone‑induced hyposensitivity to rocuronium in rat diaphragm associated with muscle‑fiber transformation

Chen,Dan; Yang,Mei‑Rong; Huang,Li‑Na; Qiu,Yu‑Wei; Li,Shi‑Tong

doi:10.3892/mmr.2013.1819

Dexamethasone‑induced hyposensitivity to rocuronium in rat diaphragm associated with muscle‑fiber transformation

Authors:
- Dan Chen
- Mei‑Rong Yang
- Li‑Na Huang
- Yu‑Wei Qiu
- Shi‑Tong Li
View Affiliations

Affiliations: Department of Anesthesiology, First People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200030, P.R. China
Published online on: November 20, 2013 https://doi.org/10.3892/mmr.2013.1819
Pages: 527-534

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the current study was to investigate the effect of chronic dexamethasone (Dex) administration on rat diaphragm function and sensitivity to rocuronium and muscle‑fiber transformation. Adult male Sprague‑Dawley rats were randomized to receive a daily intraperitoneal injection of Dex to evaluate whether alterations in diaphragm function and susceptibility to rocuronium would be induced. In addition, diaphragm contractile properties, histopathology and isometric twitch tensions of nerve‑hemidiaphragm preparations were evaluated. Dex administration led to impaired diaphragm force generation, increased fatigue resistance and a prolonged half‑relaxation time, as well as time‑to‑peak tension. Dex treatment led to desensitization of the rat diaphragm to rocuronium, as demonstrated by a shift of the rocuronium concentration‑twitch tension curves to the right. Histochemical analysis of adenosine triphosphatase revealed that the distribution and cross‑sectional area of type II fibers were decreased in rats exposed to Dex. The present study indicates that chronic Dex treatment induced alterations in muscle function and that susceptibility to rocuronium is associated with muscle fiber‑type transformation, which may aid in directing future administration of muscle relaxants.

View Figures

View References

1	Azar I, Kumar D and Betcher AM: Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids. Can Anaesth Soc J. 29:280–282. 1982. View Article : Google Scholar : PubMed/NCBI
2	Laflin MJ: Interaction of pancuronium and corticosteroids. Anesthesiology. 47:471–472. 1977. View Article : Google Scholar : PubMed/NCBI
3	Meyers EF: Partial recovery from pancuronium neuromuscular blockade following hydrocortisone administration. Anesthesiology. 46:148–150. 1977. View Article : Google Scholar
4	Soltész S, Mencke T, Stunz M, Diefenbach C, Ziegeler S and Molter GP: Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone. Acta Anaesthesiol Scand. 53:443–448. 2009.PubMed/NCBI
5	Soltész S, Mencke T, Mey C, Röhrig S, Diefenbach C and Molter GP: Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease. Br J Anaesth. 100:798–802. 2008.
6	Parr SM, Galletly DC and Robinson BJ: Betamethasone-induced resistance to vecuronium: a potential problem in neurosurgery? Anaesth Intensive Care. 19:103–105. 1991.PubMed/NCBI
7	Arts WF and Oosterhuis HJ: Effect of prednisolone on neuromuscular blocking in mice in vivo. Neurology. 25:1088–1090. 1975. View Article : Google Scholar : PubMed/NCBI
8	Robinson BJ, Lee E, Rees D, Purdie GL and Galletly DC: Betamethasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro. Anesth Analg. 74:762–765. 1992. View Article : Google Scholar : PubMed/NCBI
9	Parr SM, Robinson BJ, Rees D and Galletly DC: Interaction between betamethasone and vecuronium. Br J Anaesth. 67:447–451. 1991. View Article : Google Scholar : PubMed/NCBI
10	Dal Belo CA, Leite GB, Fontana MD, et al: New evidence for a presynaptic action of prednisolone at neuromuscular junctions. Muscle Nerve. 26:37–43. 2002.PubMed/NCBI
11	Dalkara T and Onur R: Facilitatory effects of dexamethasone on neuromuscular transmission. Exp Neurol. 95:116–125. 1987. View Article : Google Scholar : PubMed/NCBI
12	Leeuwin RS, Njio KD, Belling GA and van den Hoven S: Glucocorticoid-induced changes in synaptic vesicles of rat phrenic nerve terminals. Arch Int Pharmacodyn Ther. 266:200–207. 1983.PubMed/NCBI
13	Leeuwin RS, Veldsema-Currie RD, van Wilgenburg H and Ottenhof M: Effects of corticosteroids on neuromuscular blocking actions of d-tubocurarine. Eur J Pharmacol. 69:165–173. 1981. View Article : Google Scholar : PubMed/NCBI
14	Van Wilgenburg H, Njio KD, Belling GA and Van den Hoven S: Effects of corticosteroids on the myoneural junction. A morphometric and electrophysiological study. Eur J Pharmacol. 84:129–137. 1982.PubMed/NCBI
15	Veldsema-Currie RD, Wolters E and Leeuwin RS: The effect of corticosteroids and hemicholinium-3 on choline uptake and incorporation into acetylcholine in rat diaphragm. Eur J Pharmacol. 35:399–402. 1976. View Article : Google Scholar : PubMed/NCBI
16	Pereira RM and Freire de Carvalho J: Glucocorticoid-induced myopathy. Joint Bone Spine. 78:41–44. 2011. View Article : Google Scholar
17	Yamamoto D, Maki T, Herningtyas EH, et al: Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve. 41:819–827. 2010. View Article : Google Scholar : PubMed/NCBI
18	Inder WJ, Jang C, Obeyesekere VR and Alford FP: Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1 - implications for steroid-induced myopathy. Clin Endocrinol (Oxf). 73:126–132. 2010.
19	Schakman O, Gilson H, Kalista S and Thissen JP: Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res. 72(Suppl 1): 36–41. 2009. View Article : Google Scholar
20	Schakman O, Gilson H and Thissen JP: Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 197:1–10. 2008. View Article : Google Scholar
21	Nava S, Gayan-Ramirez G, Rollier H, et al: Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med. 153:1888–1896. 1996. View Article : Google Scholar : PubMed/NCBI
22	van Balkom RH, van der Heijden HF, van Herwaarden CL and Dekhuijzen PN: Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med. 45:114–122. 1994.PubMed/NCBI
23	Dekhuijzen PN, Gayan-Ramirez G, de Bock V, Dom R and Decramer M: Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest. 92:1534–1542. 1993. View Article : Google Scholar : PubMed/NCBI
24	Fletcher LK, Powers SK, Coombes JS, et al: Glucocorticoid- induced alterations in the rate of diaphragmatic fatigue. Pharmacol Res. 42:61–68. 2000. View Article : Google Scholar : PubMed/NCBI
25	van Balkom RH, Dekhuijzen PN, Folgering HT, Veerkamp JH, Fransen JA and van Herwaarden CL: Effects of long-term low-dose methylprednisolone on rat diaphragm function and structure. Muscle Nerve. 20:983–990. 1997.PubMed/NCBI
26	Van Balkom RH, Zhan WZ, Prakash YS, Dekhuijzen PN and Sieck GC: Corticosteroid effects on isotonic contractile properties of rat diaphragm muscle. J Appl Physiol. 83:1062–1067. 1997.PubMed/NCBI
27	Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, et al: Rat diaphragm contractility and histopathology are affected differently by low dose treatment with methylprednisolone and deflazacort. Eur Respir J. 8:824–830. 1995.PubMed/NCBI
28	Sieck GC, van Balkom RH, Prakash YS, Zhan WZ and Dekhuijzen PN: Corticosteroid effects on diaphragm neuromuscular junctions. J Appl Physiol. 86:114–122. 1999.PubMed/NCBI
29	Sieck GC and Prakash YS: Morphological adaptations of neuromuscular junctions depend on fiber type. Can J Appl Physiol. 22:197–230. 1997. View Article : Google Scholar : PubMed/NCBI
30	Prakash YS, Miller SM, Huang M and Sieck GC: Morphology of diaphragm neuromuscular junctions on different fibre types. J Neurocytol. 25:88–100. 1996. View Article : Google Scholar : PubMed/NCBI
31	Hemmerling TM and Donati F: Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can J Anaesth. 50:779–794. 2003. View Article : Google Scholar : PubMed/NCBI
32	Hemmerling TM, Schmidt J, Hanusa C, Wolf T and Schmitt H: Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth. 85:856–860. 2000. View Article : Google Scholar
33	Cantineau JP, Porte F, d’Honneur G and Duvaldestin P: Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology. 81:585–590. 1994. View Article : Google Scholar : PubMed/NCBI
34	Donati F, Meistelman C and Plaud B: Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology. 73:870–875. 1990. View Article : Google Scholar : PubMed/NCBI
35	Pansard JL, Chauvin M, Lebrault C, Gauneau P and Duvaldestin P: Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology. 67:326–330. 1987. View Article : Google Scholar : PubMed/NCBI
36	Donati F, Meistelman C and Plaud B: Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology. 74:833–837. 1991. View Article : Google Scholar : PubMed/NCBI
37	Day NS, Blake GJ, Standaert FG and Dretchen KL: Characterization of the train-of-four response in fast and slow muscles: effect of d-tubocurarine, pancuronium, and vecuronium. Anesthesiology. 58:414–417. 1983. View Article : Google Scholar : PubMed/NCBI
38	Ma K, Mallidis C, Bhasin S, et al: Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 285:E363–E371. 2003.PubMed/NCBI
39	Burke RE, Levine DN, Tsairis P and Zajac FE III: Physiological types and histochemical profiles in motor units of the cat gastrocnemius. J Physiol. 234:723–748. 1973. View Article : Google Scholar : PubMed/NCBI
40	Brooke MH and Kaiser KK: Three ‘myosin adenosine triphosphatase’ systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem. 18:670–672. 1970.
41	Peter JB, Barnard RJ, Edgerton VR, Gillespie CA and Stempel KE: Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits. Biochemistry. 11:2627–2633. 1972. View Article : Google Scholar : PubMed/NCBI
42	Sieck GC, Lewis MI and Blanco CE: Effects of undernutrition on diaphragm fiber size, SDH activity, and fatigue resistance. J Appl Physiol. 66:2196–2205. 1989.PubMed/NCBI
43	Lewis MI, Sieck GC, Fournier M and Belman MJ: Effect of nutritional deprivation on diaphragm contractility and muscle fiber size. J Appl Physiol. 60:596–603. 1986.PubMed/NCBI
44	Koerts-De Lang E, Schols AM, Wouters EF, Gayan-Ramirez G and Decramer M: Contractile properties and histochemical characteristics of the rat diaphragm after prolonged triamcinolone treatment and nutritional deprivation. J Muscle Res Cell Motil. 19:549–555. 1998.
45	Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R and Decramer M: Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol. 78:629–637. 1995.PubMed/NCBI
46	Lewis MI and Sieck GC: Effect of acute nutritional deprivation on diaphragm structure and function in adolescent rats. J Appl Physiol. 73:974–978. 1992.PubMed/NCBI
47	Van Wilgenburg H: The effect of prednisolone on neuromuscular transmission in the rat diaphragm. Eur J Pharmacol. 55:355–361. 1979.
48	Wilson RW, Ward MD and Johns TR: Corticosteroids: a direct effect at the neuromuscular junction. Neurology. 24:1091–1095. 1974. View Article : Google Scholar : PubMed/NCBI
49	Kotsarini C, Griffiths PD, Wilkinson ID and Hoggard N: A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery. 67:1799–1815. 2010. View Article : Google Scholar : PubMed/NCBI
50	Kularatne SA, Walathara C, Mahindawansa SI, et al: Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study. Postgrad Med J. 85:525–529. 2009. View Article : Google Scholar : PubMed/NCBI
51	Hardy JR, Rees E, Ling J, et al: A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 15:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
52	Leeuwin RS and Wolters EC: Effect of corticosteroids on sciatic nerve-tibialis anterior muscle of rats treated with hemicholinium-3. An experimental approach to a possible mechanism of action of corticosteroids in myasthenia gravis. Neurology. 27:171–177. 1977. View Article : Google Scholar
53	Arts WF and Oosterhuis HJ: Long-term effect of glucocorticosteroids on neuromuscular blocking in mice. J Neurol Neurosurg Psychiatry. 40:675–677. 1977. View Article : Google Scholar : PubMed/NCBI
54	Wolters MJ and Leeuwin RS: Effect of corticosteroids on the phrenic nerve-diaphragm of preparation treated with hemicholinium. A possible model of myasthenia gravis. Neurology. 26:574–578. 1976. View Article : Google Scholar : PubMed/NCBI
55	Tomlinson ES, Maggs JL, Park BK and Back DJ: Dexamethasone metabolism in vitro: species differences. J Steroid Biochem Mol Biol. 62:345–352. 1997. View Article : Google Scholar : PubMed/NCBI
56	Crossland H, Constantin-Teodosiu D, Greenhaff PL and Gardiner SM: Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol. 588:1333–1347. 2010. View Article : Google Scholar : PubMed/NCBI
57	Kitano M, Ishinaga H, Shimizu T, Takeuchi K and Majima Y: Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea. Pharmacology. 87:56–62. 2011. View Article : Google Scholar : PubMed/NCBI
58	Proost JH, Eriksson LI, Mirakhur RK, Roest G and Wierda JM: Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth. 85:717–723. 2000. View Article : Google Scholar : PubMed/NCBI
59	Ito S, Nagata O and Ozaki M: Estimated blood concentration of rocuronium administrated by continuous infusion to maintain an appropriate neuromuscular blockade under propofol anesthesia. Masui. 59:82–86. 2010.(In Japanese).
60	Dragne A, Varin F, Plaud B and Donati F: Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth. 49:353–360. 2002. View Article : Google Scholar
61	Braunstein PW Jr and DeGirolami U: Experimental corticosteroid myopathy. Acta Neuropathol. 55:167–172. 1981. View Article : Google Scholar